{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:23:12Z","timestamp":1760707392657},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1974,3,1]],"date-time":"1974-03-01T00:00:00Z","timestamp":131328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacologia"],"published-print":{"date-parts":[[1974,3]]},"DOI":"10.1007\/bf00421216","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T20:51:25Z","timestamp":1100033485000},"page":"11-20","source":"Crossref","is-referenced-by-count":96,"title":["l-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects"],"prefix":"10.1007","volume":"34","author":[{"given":"Dennis L.","family":"Murphy","sequence":"first","affiliation":[]},{"given":"Max","family":"Baker","sequence":"additional","affiliation":[]},{"given":"Frederick K.","family":"Goodwin","sequence":"additional","affiliation":[]},{"given":"Halbert","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Joel","family":"Kotin","sequence":"additional","affiliation":[]},{"suffix":"Jr.","given":"William E.","family":"Bunney","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF00421216_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005053-196308000-00004","volume":"137","author":"G. Alexander","year":"1963","unstructured":"Alexander, G., Curtis, G. S., III, Sprince, H., Crosley, A. P.: l-methionine and l-tryptophan feedings in non-psychotic and schizophrenic patients with\/without tranylcypromine. J. nerv. ment. Dis. 137, 135\u2013142 (1963)","journal-title":"J. nerv. ment. Dis."},{"key":"BF00421216_CR2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(66)92028-9","volume":"II","author":"G. W. Ashcroft","year":"1966","unstructured":"Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., MacDougall, E. J., Stanton, J. B., Binns, J. F.: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological disease. Lancet 1966 II, 1049\u20131052","journal-title":"Lancet"},{"key":"BF00421216_CR3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.1965.tb06775.x","volume":"12","author":"G. W. Ashcroft","year":"1965","unstructured":"Ashcroft, G. W., Eccleston, D., Crawford, T. B. B.: 5-Hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading-I. Methods. J. Neuroehem. 12, 483\u2013492 (1965)","journal-title":"J. Neuroehem."},{"key":"BF00421216_CR4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1176\/ajp.128.6.688","volume":"128","author":"A. Beigel","year":"1971","unstructured":"Beigel, A., Murphy, D. L.: Assessing clinical characteristics of the manic state. Amer. J. Psychiat. 128, 688\u2013699 (1971)","journal-title":"Amer. J. Psychiat."},{"key":"BF00421216_CR5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(68)92459-8","volume":"II","author":"H. R. Bourne","year":"1968","unstructured":"Bourne, H. R., Bunney, W. E., Colburn, R. W., Davis, J. N., Davis, J. M., Shaw, D. M., Coppen, A. J.: Noradrenaline, 5-hydroxytryptamine and 5-hydroxyin-doleacetic acid in the hindbrains of suicidal patients. Lancet 1968 II, 805\u2013808","journal-title":"Lancet"},{"key":"BF00421216_CR6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0028-3908(69)90046-X","volume":"8","author":"M. B. Bowers","year":"1969","unstructured":"Bowers, M. B., Henninger, G. R., Gerbode, F.: Cerebrospinal fluid 5-hydroxy-indoleacetic acid and homovanillic acid in psychiatric patients. Int. J. Neuropharmacol. 8, 255\u2013262 (1969)","journal-title":"Int. J. Neuropharmacol."},{"key":"BF00421216_CR7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1176\/ajp.127.7.872","volume":"127","author":"W. E. Bunney Jr.","year":"1971","unstructured":"Bunney, W. E., Jr., Brodie, H. K. H., Murphy, D. L., Goodwin, F. K.: Studies of alpha-methyl-para-tyrosine, l-Dopa, and tryptophan in depression and mania. Amer. J. Psychiat. 127, 872\u2013881 (1971)","journal-title":"Amer. J. Psychiat."},{"key":"BF00421216_CR8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/archpsyc.1963.01720150090010","volume":"9","author":"W. E. Bunney Jr.","year":"1963","unstructured":"Bunney, W. E., Jr., Hamburg, D. A.: Methods for reliable longitudinal observation of behavior. Arch. gen. Psychiat. 9, 280\u2013294 (1963)","journal-title":"Arch. gen. Psychiat."},{"key":"BF00421216_CR9","first-page":"529","volume-title":"Handbook of experimental pharmacology, vol. 19","author":"A. Carlsson","year":"1965","unstructured":"Carlsson, A.: 5-Hydroxytryptamine and related compounds. In: Handbook of experimental pharmacology, vol. 19, p. 529. Berlin-Heidelberg-New York: Springer 1965."},{"key":"BF00421216_CR10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","volume":"180","author":"A. Carlsson","year":"1957","unstructured":"Carlsson, A., Linquist, M., Magnusson, T.: 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature (Lond.) 180, 1200 (1957)","journal-title":"Nature (Lond.)"},{"key":"BF00421216_CR11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/cpt1971125743","volume":"12","author":"B. J. Carroll","year":"1971","unstructured":"Carroll, B. J.: Monoamine precursors in the treatment of depression. Clin. Pharmacol. Ther. 12, 743\u2013761 (1971)","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF00421216_CR12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(70)90255-2","volume":"II","author":"B. J. Carroll","year":"1970","unstructured":"Carroll, B. J., Mowbray, R. M., Davies, B. M.: l-tryptophan in depression. Lancet 1970 II, 776","journal-title":"Lancet"},{"key":"BF00421216_CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.pa.13.040173.001145","volume":"13","author":"T. N. Chase","year":"1973","unstructured":"Chase, T. N., Murphy, D. L.: Serotonin and central nervous system function. Ann. Rev. Pharmacol. 13, 181\u2013197 (1973)","journal-title":"Ann. Rev. Pharmacol."},{"key":"BF00421216_CR14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(69)92697-X","volume":"II","author":"A. Coppen","year":"1969","unstructured":"Coppen, A., Prange, A. J., Whybrow, P. C., Noguera, R., Paez, J. M.: Methysergide in mania. Lancet 1969 II, 338\u2013340","journal-title":"Lancet"},{"key":"BF00421216_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0140-6736(63)91084-5","volume":"I","author":"A. Coppen","year":"1963","unstructured":"Coppen, A., Shaw, D. M., Farrell, J. P.: Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet 1963 I, 79\u201381","journal-title":"Lancet"},{"key":"BF00421216_CR16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(67)91894-6","volume":"II","author":"A. Coppen","year":"1967","unstructured":"Coppen, A., Shaw, D. M., Herzberg, B., Maggs, R.: Tryptophan in the treatment of depression. Lancet 1967 II, 1178\u20131180","journal-title":"Lancet"},{"key":"BF00421216_CR17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archpsyc.1972.01750210042009","volume":"26","author":"A. Coppen","year":"1972","unstructured":"Coppen, A., Whybrow, P. C., Noguera, R., Maggs, R., Prange, A. J., Jr.: The comparative antidepressant value of l-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch. gen. Psychiat. 26, 234\u2013241 (1972)","journal-title":"Arch. gen. Psychiat."},{"key":"BF00421216_CR18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1212\/WNL.13.5.431","volume":"13","author":"G. Curzon","year":"1963","unstructured":"Curzon, G., Ettlinger, G., Cole, M., Walsh, J.: The biochemical, behavioral, and neurologic effects of high l-tryptophan intake in the Rhesus monkey. Neurology (Minneap.) 13, 431\u2013428 (1963)","journal-title":"Neurology (Minneap.)"},{"key":"BF00421216_CR19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1471-4159.1966.tb04320.x","volume":"13","author":"S. J. Dencker","year":"1966","unstructured":"Dencker, S. J., Malm, V., Roos, B.-E., Werdinius, B.: Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J. Neurochem. 13, 1545\u20131548 (1966)","journal-title":"J. Neurochem."},{"key":"BF00421216_CR20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archpsyc.1972.01750220074014","volume":"26","author":"D. L. Dunner","year":"1972","unstructured":"Dunner, D. L., Goodwin, F. K.: The effect of l-tryptophan on brain serotonin metabolism in depressed patients. Arch. gen. Psychiat. 26, 364\u2013366 (1972)","journal-title":"Arch. gen. Psychiat."},{"key":"BF00421216_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/jnnp.33.2.269","volume":"33","author":"D. Eccleston","year":"1970","unstructured":"Eccleston, D., Ashcroft, G. W., Crawford, B. B., Stanton, J. B., Wood, D., McTurk, P. H.: Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. J. Neurol. Neurosurg. Psychiat. 33, 269\u2013272 (1970)","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"BF00421216_CR22","volume-title":"Serotonin","author":"S. Garattini","year":"1965","unstructured":"Garattini, S., Valzelli, L.: Serotonin. Amsterdam: Elsevier 1965."},{"key":"BF00421216_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archpsyc.1971.01750130003001","volume":"25","author":"E. S. Gershon","year":"1971","unstructured":"Gershon, E. S., Dunner, D. L., Goodwin, F. K.: Toward a biology of affective disorders. Arch. gen. Psychiat. 25, 1\u201315 (1971)","journal-title":"Arch. gen. Psychiat."},{"key":"BF00421216_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-3956(69)90013-2","volume":"7","author":"A. H. Glassman","year":"1969","unstructured":"Glassman, A. H., Platman, S. R.: Potentiation of a monoamine oxidase inhibitor by tryptophan. J. psychiat. Res. 7, 83\u201388 (1969)","journal-title":"J. psychiat. Res."},{"key":"BF00421216_CR25","first-page":"341","volume":"2","author":"F. K. Goodwin","year":"1970","unstructured":"Goodwin, F. K., Murphy, D. L., Brodie, H. K. H., Bunney, W. E., Jr.: l-dopa, catecholamines and behavior: a clinical and biochemical study in depressed patients. Biol. Psychiat. 2, 341\u2013366 (1970)","journal-title":"Biol. Psychiat."},{"key":"BF00421216_CR26","volume-title":"Serotonin and behavior","author":"F. K. Goodwin","year":"1972","unstructured":"Goodwin, F. K., Post, R. M.: The use of probenecid in high doses for the estimation of central serotonin turnover in affective illness and addicts on methadone. In: Serotonin and behavior, J. Barchas and E. Usdin, Eds. New York: Academic Press 1972"},{"key":"BF00421216_CR27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.1971.tb12034.x","volume":"18","author":"D. G. Grahame-Smith","year":"1971","unstructured":"Grahame-Smith, D. G.: Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and l-tryptophan. J. Neurochem. 18, 1053\u20131066 (1971)","journal-title":"J. Neurochem."},{"key":"BF00421216_CR28","first-page":"89","volume":"134","author":"S. M. Hess","year":"1961","unstructured":"Hess, S. M., Doepfner, W.: Behavioral effects and brain amine content in rats. Arch. int. Pharmacodyn. 134, 89\u201399 (1961)","journal-title":"Arch. int. Pharmacodyn."},{"key":"BF00421216_CR29","volume-title":"Diagnosis and drug treatment of psychiatric disorders","author":"D. F. Klein","year":"1969","unstructured":"Klein, D. F., Davis, J. M.: Diagnosis and drug treatment of psychiatric disorders. Baltimore: Williams and Wilkins Co. 1969"},{"key":"BF00421216_CR30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1176\/ajp.129.6.679","volume":"129","author":"J. Kotin","year":"1972","unstructured":"Kotin, J., Goodwin, F. K.: Depression during mania: clinical observations and theoretical implications. Amer. J. Psychiat. 129, 679\u2013686 (1972)","journal-title":"Amer. J. Psychiat."},{"key":"BF00421216_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(69)91140-4","volume":"I","author":"I. P. Lapin","year":"1969","unstructured":"Lapin, I. P., Oxenkrug, G. F.: Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1969 I, 132\u2013136","journal-title":"Lancet"},{"key":"BF00421216_CR32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archneurpsyc.1958.02340070140021","volume":"80","author":"J. W. Lauer","year":"1958","unstructured":"Lauer, J. W., Inskip, W. M., Bernsohn, J., Zeller, E. A.: Observations on schizophrenic patients after iproniazid and tryptophan. Arch. Neurol. Psychiat. (Chic.) 80, 122\u2013130 (1958)","journal-title":"Arch. Neurol. Psychiat. (Chic.)"},{"key":"BF00421216_CR33","volume-title":"The psychoanalysis of elation","author":"B. Lewin","year":"1950","unstructured":"Lewin, B.: The psychoanalysis of elation. New York: W. W. Norton and Comp. 1950"},{"key":"BF00421216_CR34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1471-4159.1968.tb06827.x","volume":"15","author":"A. T. B. Moir","year":"1968","unstructured":"Moir, A. T. B., Eccleston, D.: The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J. Neurochem. 15, 1093\u20131108 (1968)","journal-title":"J. Neurochem."},{"key":"BF00421216_CR35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1176\/ajp.129.2.141","volume":"129","author":"D. L. Murphy","year":"1972","unstructured":"Murphy, D. L.: Amine precursors, amines and false neurotransmitters in depressed patients. Amer. J. Psychiat. 129, 144\u2013148 (1972)","journal-title":"Amer. J. Psychiat."},{"key":"BF00421216_CR36","first-page":"472","volume-title":"Neurotransmitters, research publications of the association for research in nervous and mental disease, I","author":"D. L. Murphy","year":"1972","unstructured":"Murphy, D. L.: l-dopa, behavioral activation and psychopathology. In: Neurotransmitters, research publications of the association for research in nervous and mental disease, I. J. Kopin, Ed., vol. 50, pp. 472\u2013493. Baltimore: Williams and Wilkins 1972"},{"key":"BF00421216_CR37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/229135a0","volume":"229","author":"D. L. Murphy","year":"1971","unstructured":"Murphy, D. L., Brodie, H. K. H., Goodwin, F. K., Bunney, W. E., Jr.: Regular induction of hypomania by l-dopa in \u201cbipolar\u201d manic-depressive patients. Nature (Lond.) 229, 135\u2013136 (1971)","journal-title":"Nature (Lond.)"},{"key":"BF00421216_CR38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/ajp.130.1.79","volume":"130","author":"D. L. Murphy","year":"1973","unstructured":"Murphy, D. L., Goodwin, F. K., Brodie, H. K. H., Bunney, W. E., Jr.: l-dopa, dopamine and hypomania. Amer. J. Psychiat. 130, 79\u201382 (1973)","journal-title":"Amer. J. Psychiat."},{"key":"BF00421216_CR39","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/ajp.128.11.1351","volume":"128","author":"D. L. Murphy","year":"1972","unstructured":"Murphy, D. L., Weiss, R.: Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. Amer. J. Psychiat. 128, 1351\u20131357 (1972)","journal-title":"Amer. J. Psychiat."},{"key":"BF00421216_CR40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00403563","volume":"20","author":"G. Nordin","year":"1971","unstructured":"Nordin, G., Ottoson, J.-O., Roos, B.-E.: Influence of convulsive therapy on 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogenous depression. Psychopharmacologia (Berl.) 20, 315\u2013320 (1971)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"BF00421216_CR41","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.10.12.1076","volume":"10","author":"J. A. Oates","year":"1960","unstructured":"Oates, J. A., Sjoerdsma, A.: Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology (Minneap.) 10, 1076\u20131078 (1960)","journal-title":"Neurology (Minneap.)"},{"key":"BF00421216_CR42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archpsyc.1971.01750160066012","volume":"25","author":"R. Papeschi","year":"1971","unstructured":"Papeschi, R., McClure, D. J.: Homovanillic and 5-hydroxyindoleacetic acid in cerebrosphinal fluid of depressed patients. Arch. gen. Psychiat. 25, 354\u2013358 (1971)","journal-title":"Arch. gen. Psychiat."},{"key":"BF00421216_CR43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(63)90271-X","volume":"II","author":"C. M. B. Pare","year":"1963","unstructured":"Pare, C. M. B.: Potentiation of monoamine oxidase inhibitors by tryptophan. Lancet 1963 II, 527\u2013528","journal-title":"Lancet"},{"key":"BF00421216_CR44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(69)92442-8","volume":"II","author":"C. M. B. Pare","year":"1969","unstructured":"Pare, C. M. B., Young, D. P. U., Price, K., Stacey, R. S.: 5-Hydroxytryptamine, noradrenaline and dopamine in brainstem, hypothalamus and caudate nucleus of controls and patients committing suicide by coal gas poisoning. Lancet 1969 II, 133\u2013135","journal-title":"Lancet"},{"key":"BF00421216_CR45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.133.3446.104","volume":"133","author":"W. Pollin","year":"1961","unstructured":"Pollin, W., Cardon, P. V., Jr., Kety, S. S.: Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science 133, 104\u2013105 (1961)","journal-title":"Science"},{"key":"BF00421216_CR46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00456937","volume":"1","author":"B.-E. Roos","year":"1969","unstructured":"Roos, B.-E., Sjostrom, R.: 5-Hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patients with manic-depressive psychosis. Pharmacol. Clin. 1, 153\u2013155 (1969)","journal-title":"Pharmacol. Clin."},{"key":"BF00421216_CR47","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1192\/bjp.113.505.1407","volume":"113","author":"D. M. Shaw","year":"1967","unstructured":"Shaw, D. M., Camps, F. E., Eccleston, E.: 5-Hydroxytryptamine in the hindbrains of depressive suicides. Brit. J. Psychiat. 113, 1407\u20131411 (1967)","journal-title":"Brit. J. Psychiat."},{"key":"BF00421216_CR48","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJM196212272672603","volume":"267","author":"B. Smith","year":"1962","unstructured":"Smith, B., Prockop, D. J.: Central-nervous-system effects of ingestion of l-tryptophan by normal subjects. New Engl. J. Med. 267, 1338\u20131341 (1962)","journal-title":"New Engl. J. Med."},{"key":"BF00421216_CR49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00402638","volume":"19","author":"H. M. Praag van","year":"1971","unstructured":"van Praag, H. M., Korf, J.: Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification. Psychopharmacologia (Berl.) 19, 148\u2013152 (1971)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"BF00421216_CR50","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/2251259b0","volume":"225","author":"H. M. Praag van","year":"1970","unstructured":"van Praag, H. M., Korf, J., Puite, J.: 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressed patients treated with probenecid. Nature (Lond.) 225, 1259\u20131260 (1970)","journal-title":"Nature (Lond.)"},{"key":"BF00421216_CR51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00422098","volume":"26","author":"I. C. Wilson","year":"1972","unstructured":"Wilson, I. C., Prange, A. J., Jr.: Tryptophan in mania: Theory of affective disorders. Psychopharmacologia (Berl.) 26 (Suppl.), 76 (1972)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"BF00421216_CR52","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0140-6736(70)92015-5","volume":"II","author":"R. A. Wyatt","year":"1970","unstructured":"Wyatt, R. A., Angelman, K., Kupfer, D. J., Fram, D. H., Sjordsma, A., Snyder, F.: Effects of l-tryptophan (a neutral sedative) on human sleep. Lancet 1970 II, 842\u2013846","journal-title":"Lancet"},{"key":"BF00421216_CR53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archpsyc.1971.01750080049007","volume":"24","author":"R. A. Wyatt","year":"1971","unstructured":"Wyatt, R. A., Fram, D. H., Kupfer, D. J., Snyder, F.: Total prolonged drug-induced R. E.M. sleep suppression in anxious-depressed patients. Arch. gen. Psychiat. 24, 145\u2013155 (1971)","journal-title":"Arch. gen. Psychiat."}],"container-title":["Psychopharmacologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00421216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00421216\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00421216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00421216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T19:58:29Z","timestamp":1581969509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00421216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1974,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1974,3]]}},"alternative-id":["BF00421216"],"URL":"https:\/\/doi.org\/10.1007\/bf00421216","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1974,3]]}}}